Catalyst Pharmaceuticals, Inc.CPRXNASDAQ
LOADING
|||
EPS Growth Under Pressure
Below historical average.
Left:
||||
Year-over-year earnings per share growth rate
Latest
0.00%
↓ 100% below average
Average (39q)
59.06%
Historical baseline
Range
High:1846.03%
Low:-180.56%
Volatility
3431.7%
High variability
| Period | Value |
|---|---|
| Q3 2025 | 0.00% |
| Q2 2025 | -8.51% |
| Q1 2025 | 0.00% |
| Q4 2024 | 27.03% |
| Q3 2024 | 5.71% |
| Q2 2024 | 75.00% |
| Q1 2024 | -39.39% |
| Q4 2023 | 213.79% |
| Q3 2023 | -180.56% |
| Q2 2023 | 28.57% |
| Q1 2023 | 16.67% |
| Q4 2022 | 9.09% |
| Q3 2022 | 10.00% |
| Q2 2022 | 66.67% |
| Q1 2022 | 33.33% |
| Q4 2021 | -10.00% |
| Q3 2021 | -16.67% |
| Q2 2021 | 71.43% |
| Q1 2021 | -36.36% |
| Q4 2020 | -73.81% |
| Q3 2020 | 366.67% |
| Q2 2020 | -10.00% |
| Q1 2020 | 25.00% |
| Q4 2019 | -38.46% |
| Q3 2019 | 18.18% |
| Q2 2019 | 1846.03% |
| Q1 2019 | 95.50% |
| Q4 2018 | -75.00% |
| Q3 2018 | -33.33% |
| Q2 2018 | -7.91% |
| Q1 2018 | 5.60% |
| Q4 2017 | -19.47% |
| Q3 2017 | -6.71% |
| Q2 2017 | 22.87% |
| Q1 2017 | -19.32% |
| Q4 2016 | -5.24% |
| Q3 2016 | 13.43% |
| Q2 2016 | 15.23% |
| Q1 2016 | 7.41% |
| Q4 2015 | -30.24% |